Tumor tissue collection in this first trial, primarily designed to assess safety, did not allow performing such studies, but in future H-1PV glioblastoma trials, tumor infiltration with DCs, the CD40/CD40L axis, and costimulatory molecule expression on TAM and DCs will be worth investigating. The gene discussed is CD40LG; the disease is neoplasm.